UDG Healthcare Plc (UDG):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:UDG Healthcare Plc (UDG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10167
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アイルランド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities include contract sales outsourcing and related marketing and regulatory services; healthcare logistics based businesses; drug safety monitoring; clinical trial solutions; healthcare communications and events; outsourced packaging solutions for pharmaceutical manufacturers; drug serialization; and nursing services. The company offers its services to biotech and med-tech companies through its network of subsidiaries. The company has operations in the Americas, Europe and Asia. UDG is headquartered in Dublin, Ireland.

UDG Healthcare Plc (UDG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UDG Healthcare Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deal Details 11
Private Equity 11
H2 Equity Partners Acquires Aquilant from UDG Healthcare for USD27 Million 11
Partnerships 13
UDG Healthcare Forms Joint Venture with CMIC 13
Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 14
Acquisition 15
Healthcare 21 Acquires Aquilant from H2 Equity 15
UDG Healthcare Acquires MicroMass Communications for USD75.8 Million 16
UDG Healthcare Acquires Cambridge BioMarketing for USD35 Million 17
UDG Healthcare Plc – Key Competitors 18
UDG Healthcare Plc – Key Employees 19
UDG Healthcare Plc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 22
Financial Announcements 22
Aug 03, 2017: UDG Healthcare: Third Quarter Trading Update 22
May 23, 2017: UDG Healthcare: Interim Report 2017 24
Feb 07, 2017: UDG Healthcare: Good start to the year and full year guidance issued 27
Corporate Communications 28
Jan 30, 2018: UDG Healthcare: Directorate Change 28
Dec 19, 2017: UDG healthcare: CFO Appointment 29
Apr 12, 2017: UDG Healthcare appoints Jez Moulding as Group Chief Operating Officer and Executive Vice President of Ashfield 30
Feb 07, 2017: UDG Healthcare: Board appointment 31
Other Significant Developments 32
Jan 30, 2018: UDG Healthcare Announces First Quarter Trading Update 32
Apr 03, 2017: Daiichi Sankyo Announces Sale of Pharmaceutical Packaging Plant in Bethlehem, PA 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UDG Healthcare Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UDG Healthcare Plc, Deals By Therapy Area, 2012 to YTD 2018 8
UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
H2 Equity Partners Acquires Aquilant from UDG Healthcare for USD27 Million 11
UDG Healthcare Forms Joint Venture with CMIC 13
Cardiome Pharma Enters Into Commercialization Agreement With UDG Healthcare For Brinavess In Ireland 14
Healthcare 21 Acquires Aquilant from H2 Equity 15
UDG Healthcare Acquires MicroMass Communications for USD75.8 Million 16
UDG Healthcare Acquires Cambridge BioMarketing for USD35 Million 17
UDG Healthcare Plc, Key Competitors 18
UDG Healthcare Plc, Key Employees 19
UDG Healthcare Plc, Subsidiaries 20

List of Figures
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
UDG Healthcare Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
UDG Healthcare Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[UDG Healthcare Plc (UDG):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ABC Supply Co. Inc.:企業の戦略・SWOT・財務情報
    ABC Supply Co. Inc. - Strategy, SWOT and Corporate Finance Report Summary ABC Supply Co. Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • RCR Tomlinson Ltd (RCR):企業の財務・戦略的SWOT分析
    RCR Tomlinson Ltd (RCR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Takasago International Corporation (4914):企業の財務・戦略的SWOT分析
    Takasago International Corporation (4914) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Panalpina World Transport (Holding) Ltd.
    Panalpina World Transport (Holding) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Panalpina World Transport (Holding) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • RHÖN-KLINIKUM AG:企業の戦略・SWOT・財務分析
    RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report Summary RHÖN-KLINIKUM AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Lockheed Martin Corporation:戦略・SWOT・企業財務分析
    Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report Summary Lockheed Martin Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Tianda Pharmaceuticals Ltd (455):製薬・医療:M&Aディール及び事業提携情報
    Summary Tianda Pharmaceuticals Ltd (Tianda Pharma), a subsidiary of Tianda Group Ltd, is a healthcare supplement product manufacturer that researches, develops, manufactures and markets biotechnology, pharmaceutical and health care products. The company provides products covering various therapeutic …
  • BOC Group Life Assurance Company Limited:企業の戦略・SWOT・財務情報
    BOC Group Life Assurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary BOC Group Life Assurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Exiqon AS:医療機器:M&Aディール及び事業提携情報
    Summary Exiqon AS (Exiqon), a subsidiary of Qiagen NV, is a medical device company that develops, manufactures and markets molecular diagnostic test products. The company provides product categories such as microRNA research, incRNA research, mRNA research, DNA research, custom oligos and other reag …
  • Atkore International Group Inc (ATKR):企業の財務・戦略的SWOT分析
    Atkore International Group Inc (ATKR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Affimed GmbH (AFMD):企業の財務・戦略的SWOT分析
    Summary Affimed GmbH (Affimed), formerly Affimed Therapeutics AG, a subsidiary of Affimed NV, discovers and develops immunotherapies to treat hematologic cancers and solid tumors. The company is investigating AFM13, an innate cell engager, for the treatment of Peripheral T cell lymphoma, transformed …
  • Qube Holdings Ltd:戦略・SWOT・企業財務分析
    Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Qube Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Ascent Resources plc (AST):企業の財務・戦略的SWOT分析
    Ascent Resources plc (AST) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Theraclion SA (ALTHE):企業の財務・戦略的SWOT分析
    Summary Theraclion SA (Theraclion) is a medical device company that designs, markets, and develops high-intensity focused therapeutic ultrasound devices and equipment; and offers technical support services. The company offers echotherapy solution that combines HIFU therapy with ultrasound as a syste …
  • Eversource Energy:企業の発電所・SWOT分析2018
    Eversource Energy - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees ( …
  • Sol-Gel Technologies Ltd (SLGL):製薬・医療:M&Aディール及び事業提携情報
    Summary Sol-Gel Technologies Ltd (Sol-Gel) is a clinical-stage dermatology company that identifies, develops and commercializes branded and generic topical dermatological drug products for the treatment of skin diseases. The company’s pipeline products include vered, twin and sirs-t drug candidates. …
  • LOT Polish Airlines SA:企業の戦略・SWOT・財務情報
    LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report Summary LOT Polish Airlines SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Astex Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Astex Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Corindus Vascular Robotics Inc (CVRS):企業の財務・戦略的SWOT分析
    Summary Corindus Vascular Robotics Inc (Corindus) is a medical device company that designs, manufactures and commercializes remote robotic systems for interventional surgical procedures. The company offers next-generation CorPath GRX system, a robotic platform that enables improvements in procedural …
  • Chugoku Marine Paints Ltd (4617):企業の財務・戦略的SWOT分析
    Chugoku Marine Paints Ltd (4617) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆